One Injection of Novel Drug Cuts Systolic Blood Pressure by Up to 12 mmHg

A single subcutaneous injection of the investigational drug zilebesiran, when added to existing treatment with a standard antihypertensive medication,....

Related Keywords

Boston ,Massachusetts ,United States ,America , ,American College Of Cardiology Annual Scientific Session ,Accreditation Services ,Us Centers For Disease ,American College Of Cardiology ,Alnylam Pharmaceuticals ,Novel Drug Cuts Systolic Blood Pressure ,Alphagalileo Reader ,Standard Level ,Premium Level ,American College ,Annual Scientific ,Disease Control ,Combination With ,Results From The Phase ,Member Sections ,North America ,